ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $22,349,000 | -42.3% | 5,411,414 | +13.1% | 0.00% | -50.0% |
Q3 2016 | $38,761,000 | +9.7% | 4,785,281 | +5.6% | 0.01% | 0.0% |
Q2 2016 | $35,343,000 | +0.1% | 4,531,181 | -0.9% | 0.01% | 0.0% |
Q1 2016 | $35,306,000 | -26.8% | 4,573,313 | +2.3% | 0.01% | -27.3% |
Q4 2015 | $48,244,000 | +47.8% | 4,471,134 | -5.3% | 0.01% | +37.5% |
Q3 2015 | $32,639,000 | -15.0% | 4,723,459 | +9.0% | 0.01% | -11.1% |
Q2 2015 | $38,387,000 | -14.2% | 4,332,613 | -4.5% | 0.01% | -18.2% |
Q1 2015 | $44,742,000 | -5.2% | 4,537,734 | +17.8% | 0.01% | -8.3% |
Q4 2014 | $47,178,000 | +35.6% | 3,851,254 | +10.5% | 0.01% | +20.0% |
Q3 2014 | $34,782,000 | +29.4% | 3,485,121 | -1.9% | 0.01% | +25.0% |
Q2 2014 | $26,888,000 | +125.8% | 3,551,912 | -1.9% | 0.01% | +100.0% |
Q1 2014 | $11,910,000 | +3.3% | 3,620,099 | +4.2% | 0.00% | 0.0% |
Q4 2013 | $11,531,000 | +7.7% | 3,474,382 | -2.0% | 0.00% | 0.0% |
Q3 2013 | $10,708,000 | -57.5% | 3,545,705 | +15.2% | 0.00% | -55.6% |
Q2 2013 | $25,182,000 | – | 3,078,435 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |